Leveraging Artificial Intelligence and Machine Learning in Kinase Inhibitor Development: Advances, Challenges, and Future Prospects

Key Points

• AI and machine learning technologies enhance the development of kinase inhibitors for cancer and autoimmune disorders, improving treatment options.
• Recent advancements highlight that integrating AI can lead to significant breakthroughs in kinase inhibitor therapies, particularly in cancer management.
• Observational analysis demonstrates the clinical relevance of protein kinases in disease progression, making them key targets for new therapies.
• The study emphasizes the potential of AI and machine learning methodologies to streamline the drug development process, which may lead to faster therapeutic interventions.